Honokiol targets multiple signaling pathways such as nuclear factor κB (NF-κB), signal transducers and activator of transcription 3 (STAT3), mammalian target of rapamycin (mTOR) and epidermal growth factor receptor (EGFR), which have great relevance during cancer initiation and progression (47). The gene discussed is MTOR; the disease is cancer.